Zeneca Nolvadex
Executive Summary
Tamoxifen NDA supplement filed April 30 for breast cancer prevention in women at increased risk for the disease. The 13,388-patient Breast Cancer Prevention Trial was halted recently after an interim analysis demonstrated efficacy. FDA indicated that the sNDA will receive a six-month accelerated review ("The Pink Sheet" April 13, p. 7)...